ArticleFrontiers in oncology2026

Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case series.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.